4-Cyclopentyl-morpholine-3-carboxylic acid
|
- $423 - $1000
- Product name: 4-Cyclopentyl-morpholine-3-carboxylic acid
- CAS: 1316219-11-0
- MF: C10H17NO3
- MW: 199.25
- EINECS:
- MDL Number:MFCD18381646
- Synonyms:4-Cyclopentyl-morpholine-3-carboxylic acid;3-Morpholinecarboxylic acid, 4-cyclopentyl-
5 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 250mg
- 500mg
- 1g
- ManufacturerChemenu
- Product numberCM493756
- Product description4-Cyclopentylmorpholine-3-carboxylicacid 98%
- Packaging1g
- Price$622
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11295311
- Product description4-Cyclopentylmorpholine-3-carboxylicacid 97%
- Packaging1g
- Price$629
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number068096
- Product description4-Cyclopentyl-morpholine-3-carboxylic acid
- Packaging500mg
- Price$650
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number068096
- Product description4-Cyclopentyl-morpholine-3-carboxylic acid
- Packaging1g
- Price$1000
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number068096
- Product description4-Cyclopentyl-morpholine-3-carboxylic acid
- Packaging250mg
- Price$423
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM493756 | 4-Cyclopentylmorpholine-3-carboxylicacid 98% | 1g | $622 | 2026-05-26 | Buy |
| Crysdot | CD11295311 | 4-Cyclopentylmorpholine-3-carboxylicacid 97% | 1g | $629 | 2021-12-16 | Buy |
| Matrix Scientific | 068096 | 4-Cyclopentyl-morpholine-3-carboxylic acid | 500mg | $650 | 2021-12-16 | Buy |
| Matrix Scientific | 068096 | 4-Cyclopentyl-morpholine-3-carboxylic acid | 1g | $1000 | 2021-12-16 | Buy |
| Matrix Scientific | 068096 | 4-Cyclopentyl-morpholine-3-carboxylic acid | 250mg | $423 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




